Mirtazapine is a tetracyclic antidepressant belonging to the noradrenergic and specific serotonergic antidepressant (NaSSA) class, primarily indicated for the treatment of major depressive disorder. Laboratories… Read more
















Mirtazapine is a tetracyclic antidepressant belonging to the noradrenergic and specific serotonergic antidepressant (NaSSA) class, primarily indicated for the treatment of major depressive disorder. Laboratories rely on a comprehensive range of Mirtazapine reference standards, including pharmacopeial and non-pharmacopeial impurities, to ensure accurate quality control and regulatory compliance. These reference materials are essential for impurity profiling, allowing researchers to monitor degradation products such as N-desmethyl mirtazapine and various N-nitroso derivatives throughout the manufacturing process. Additionally, stable isotope labelled compounds are utilized as internal standards in liquid chromatography-mass spectrometry (LC-MS) assays to improve the precision of analytical method validation and pharmacokinetic studies. By providing well-characterized metabolites and synthetic analogs, this collection supports the development of robust analytical procedures necessary for maintaining the therapeutic integrity and safety of pharmaceutical products in accordance with global standards.